PATENT CLAIM ANALYSIS

Application Number: 15898151
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "254090"]

Abstract:
Disclosed herein inter alia are compositions and methods for treating cancer using 5-Br-indirubin derivatives.

Claim (Index 29):
The compound of  claim 1  for use in treating cancer in a subject in need thereof.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15757238', '15760959', '14689682', '15242318', '15796363']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.83604915898377
- 35 USC 102 Novelty (BERT): 0.5526745390679685
- Combined Prediction Score: 0.8077116969921899
- Mean Citation Score: 436.506928
- Max Citation Score: 440.4053
- Similarity Product: 307.1118695064187

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test